文献速递青光眼

基于空间模式分析的人工智能方法检测青光眼视野进展

An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究纳入7360例患者共12217只眼,将视野分解为16种原型模式并分析其权重随时间变化以定义进展。在397只眼验证队列中,原型法的kappa(0.51)和准确率(0.77)显著优于AGIS、CIGTS、MD斜率及PoPLR(P < 0.001)。

要点

  • 原型法检测视野进展的准确率(0.77)和kappa(0.51)显著优于传统方法。
  • 最常见进展模式为正常模式减弱(63.7%)及鼻侧阶梯增加(16.4%)。
  • 原型法可与MD斜率、PoPLR等指标互补,提示进展的空间模式。

核心结论

  • 基于空间模式分析的原型法可检测青光眼视野进展,并告知临床医生进展的模式类型。

研究设计与样本

  • 回顾性方法开发与临床验证研究,纳入7360例患者共12217只眼,每只眼至少有5次可靠24-2视野且随访5年、间隔至少6个月。
  • 视野被分解为16种人工智能衍生原型模式,对16个原型权重随时间做线性回归定义进展。
  • 原型法与MD斜率、AGIS评分、CIGTS评分及PoPLR比较,并由3名青光眼专家评估的子集进行验证。

主要发现

  • 方法开发队列(11817只眼)中,原型法与MD斜率(kappa 0.37)和PoPLR(kappa 0.33)的一致性高于AGIS(0.12)和CIGTS(0.22)。
  • 最常见进展模式包括正常模式减弱(63.7%)、鼻侧阶梯增加(16.4%)、高度损失增加(15.9%)、上周边缺损增加(12.1%)、旁中心/中心缺损增加(10.5%)及近全丧失增加(10.4%)。
  • 临床验证队列(397只眼,27.5%确认进展)中,原型法kappa为0.51、准确率为0.77,均显著优于AGIS(0.06和0.52)、CIGTS(0.24和0.59)、MD斜率(0.21和0.59)及PoPLR(0.26和0.60),P < 0.001。

关键数值与推荐

  • 进展定义为正常原型权重下降速率或任一视野缺损原型权重增加速率超出正常范围。
  • 验证队列中确认进展比例为27.5%,原型法准确率为0.77,kappa为0.51。

临床怎么用

  • 临床可用原型法辅助判读视野进展,并识别具体进展模式(如鼻侧阶梯、高度损失等)。
  • 原型法结果可与MD斜率、PoPLR等指标联合参考,提高进展检测一致性。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To detect visual field (VF) progression by analyzing spatial pattern changes. METHODS: We selected 12,217 eyes from 7360 patients with at least five reliable 24-2 VFs and 5 years of follow-up with an interval of at least 6 months. VFs were decomposed into 16 archetype patterns previously derived by artificial intelligence techniques. Linear regressions were applied to the 16 archetype weights of VF series over time. We defined progression as the decrease rate of the normal archetype or any increase rate of the 15 VF defect archetypes to be outside normal limits. The archetype method was compared with mean deviation (MD) slope, Advanced Glaucoma Intervention Study (AGIS) scoring, Collaborative Initial Glaucoma Treatment Study (CIGTS) scoring, and the permutation of pointwise linear regression (PoPLR), and was validated by a subset of VFs assessed by three glaucoma specialists. RESULTS: In the method development cohort of 11,817 eyes, the archetype method agreed more with MD slope (kappa: 0.37) and PoPLR (0.33) than AGIS (0.12) and CIGTS (0.22). The most frequently progressed patterns included decreased normal pattern (63.7%), and increased nasal steps (16.4%), altitudinal loss (15.9%), superior-peripheral defect (12.1%), paracentral/central defects (10.5%), and near total loss (10.4%). In the clinical validation cohort of 397 eyes with 27.5% of confirmed progression, the agreement (kappa) and accuracy (mean of hit rate and correct rejection rate) of the archetype method (0.51 and 0.77) significantly (P < 0.001 for all) outperformed AGIS (0.06 and 0.52), CIGTS (0.24 and 0.59), MD slope (0.21 and 0.59), and PoPLR (0.26 and 0.60). CONCLUSIONS: The archetype method can inform clinicians of VF progression patterns.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang M, Shen LQ, Pasquale LR, et al. An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis. Invest Ophthalmol Vis Sci. 2019. PMID: 30682206. doi:10.1167/iovs.18-25568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。